Director John Philip Coghlan filed a Form 4 with the SEC on September 3, 2026, reporting the sale of 4,000 shares of Life360, Inc. common stock on September 1, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Key Highlights
- Shares sold: 4,000 shares of Life360, Inc. common stock disposed of on September 1, 2026
- Weighted average price: $41.97 per share, with individual transactions ranging from $41.72 to $42.21 per share
- Trading plan: Sale was executed under a Rule 10b5-1 plan adopted by Coghlan on December 8, 2025
- Indirect holdings after transaction: 16,431 shares held indirectly by the John Coghlan Living Trust
- Direct holdings after transaction: 5,676 shares held directly, including 4,840 restricted stock units
- Additional indirect holdings: 55,494 shares held indirectly by The John Philip Coghlan 2025 Grantor Retained Annuity Trust
Coghlan's Share Sale and Beneficial Ownership Details at Life360
According to the filing, John Philip Coghlan, a director of Life360, Inc. (NASDAQ:LIF), sold 4,000 shares of the company's common stock on September 1, 2026. The shares were disposed of at a weighted average price of $41.97, with individual transaction prices ranging from $41.72 to $42.21 per share, inclusive. The filing notes that Coghlan undertakes to provide full details on the number of shares sold at each separate price upon request.
The filing discloses that the sale was made pursuant to a Rule 10b5-1 trading plan that Coghlan adopted on December 8, 2025. According to the filing, the plan is "a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company." The form was signed by Jay Sood as Attorney-in-Fact on September 3, 2026.
Following the reported transaction, the filing shows Coghlan's beneficial ownership across several positions. He holds 5,676 shares directly, which the filing notes includes 4,840 restricted stock units, each representing a contingent right to receive one share of common stock upon vesting. Indirectly, 16,431 shares are held by the John Coghlan Living Trust, and 55,494 shares are held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
What Was Disclosed
The filing reports a single open-market sale of 4,000 Life360 common shares by director John Philip Coghlan on September 1, 2026, at a weighted average price of $41.97, under a Rule 10b5-1 plan adopted December 8, 2025, with remaining beneficial ownership spread across direct and indirect accounts.




Please wait processing your request...